Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy

Human cytomegalovirus (HCMV) causes considerable morbidity and disability in high risk, immunocompromised populations including recipients of solid organ transplants, and fetuses whose immune systems are not yet mature. Vaccines aimed at ameliorating the severity of disease and preventing HCMV infec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Xia, Lin, Su, Ruopeng, An, Zhiqiang, Fu, Tong-Ming, Luo, Wenxin
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5806647/
https://ncbi.nlm.nih.gov/pubmed/29053403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1391433
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars